Physiological cost of antibiotic resistance: Insights from a ribosome variant in bacteria

Sci Adv. 2024 Nov 15;10(46):eadq5249. doi: 10.1126/sciadv.adq5249. Epub 2024 Nov 15.

Abstract

Antibiotic-resistant ribosome variants arise spontaneously in bacterial populations; however, their impact on the overall bacterial physiology remains unclear. We studied the naturally arising antibiotic-resistant L22* ribosome variant of Bacillus subtilis and identified a Mg2+-dependent physiological cost. Coculture competition experiments show that Mg2+ limitation hinders the growth of the L22* variant more than the wild type (WT), even under antibiotic pressure. This growth disadvantage of L22* cells is not due to lower ribosome abundance but rather due to reduced intracellular Mg2+ levels. Coarse-grained elastic-network modeling of ribosome conformational dynamics suggests that L22* ribosomes associate more tightly with Mg2+ when compared to WT. We combined the structural modeling and experimental measurements in a steady-state model to predict cellular adenosine 5'-triphosphate (ATP) levels, which also depend on Mg2+. Experiments confirmed a predicted ATP drop in L22* cells under Mg2+ limitation, while WT cells were less affected. Intracellular competition for a finite Mg2+ pool can thus suppress the establishment of an antibiotic-resistant ribosome variant.

MeSH terms

  • Adenosine Triphosphate* / metabolism
  • Anti-Bacterial Agents* / pharmacology
  • Bacillus subtilis* / genetics
  • Bacillus subtilis* / metabolism
  • Drug Resistance, Bacterial / genetics
  • Magnesium* / metabolism
  • Ribosomes* / metabolism

Substances

  • Magnesium
  • Adenosine Triphosphate
  • Anti-Bacterial Agents